Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
about
Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.Neuroimaging in Parkinson disease: from research setting to clinical practice.SPECT imaging evaluation in movement disorders: far beyond visual assessment.The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study.Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates.A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease.Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease.Changes in clinical management and diagnosis following DaTscan SPECT imaging in patients with clinically uncertain parkinsonian syndromes: a 12-week follow-up study.Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis.
P2860
Q30480599-E5E88DF8-8E9E-4B08-B163-975AEC3FD7AAQ30868628-F6D2B267-6B64-4965-9C8C-499ED6DA4256Q37815026-5C25B69B-5C6E-47AB-80B6-5170CD222935Q41829532-8C3E50C6-41A8-4B07-A362-4A852B5FED97Q41969925-79FC02AA-E0F2-41D8-8EBC-8E799EC912A2Q42291087-4E3B5054-D132-4D90-91A1-4C7366136D5EQ42927155-487A74E7-6028-4536-803F-BAD542601F69Q46767686-66D6DEC9-56D9-4A39-BAB7-EFB3EB2A1270Q48444801-A34B29F6-C9EE-4CFC-B673-2EED0A4A0014Q55223077-96FF547D-5351-496C-A4D9-FCA3CAC3982D
P2860
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@en
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@nl
type
label
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@en
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@nl
prefLabel
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@en
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@nl
P2093
P1476
Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.
@en
P2093
Annemette Løkkegaard
Lars Friberg
Lene M Werdelin
P2888
P304
P356
10.1007/S00259-002-0938-7
P577
2002-09-13T00:00:00Z